- Congratulations!! - What do you think of current price? Especially in the context of the entire biotech industry's valuation (example BBH). - Would love to get thoughts from long term biotech investors like you. Thanks.
I've followed since Bristol Myers bought Du Pont Pharmaceuticals, and Du Pont's best scientific guys refused to go along. They had the guts to break off and form Incyte. That's why it's headquartered in Wilmington, Delaware. They took a blow when their first drug, a potential best in class HIV drug, had to jettisoned because of liver toxicity, but persevered, and have produced a future powerhouse. I take my hat off to them.
my takeaway: these pharmas take much, much longer to develop than projected, and often burn and fade away. Occasionally, like incy, they blossom after years. my guess: acquired within a year or two for a substantial premium to current value. Holding on.